U-M an Autoimmunity Center of Excellence for basic and clinical research

Only institute to be named ACE in both disciplines

In spring 2014, U-M received Autoimmunity Center of Excellence (ACE) awards for clinical and basic research – the only institution to be awarded both.  The ACE program is designed to encourage and enable collaborative basic and clinical research across scientific disciplines to identify effective treatments for autoimmune diseases.  It is a cooperative effort of the National Institute of Allergy and Infectious Diseases (NIAID), the Office of Research on Women’s Health (ORWH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), all components of the National Institutes of Health (NIH).

Autoimmunity Centers of Excellence logo
Autoimmunity Centers of Excellence

Michigan is one of only 10 institutions in the U.S. to be named an Autoimmunity Center of Excellence. In total, four programs have been awarded ACEs for clinical research and seven for basic research, with Michigan the only program to receive the distinction for both disciplines. 

Together, the centers will conduct clinical trials and basic research on new immune-based therapies for autoimmune diseases, enhancing interactions between scientists and clinicians in order to accelerate the translation of research findings into medical applications.

David Fox, M.D. and Dinesh Khanna, M.D., M.S. direct the U-M Clinical ACE, and Bruce Richardson, M.D., Ph.D. and Amr Sawalha, M.D. direct the U-M Basic ACE.